CADL
Price
$4.30
Change
+$0.01 (+0.23%)
Updated
Nov 14 closing price
INKT
Price
$0.75
Change
-$0.04 (-5.06%)
Updated
Nov 14 closing price
124 days until earnings call
Ad is loading...

CADL vs INKT

Header iconCADL vs INKT Comparison
Open Charts CADL vs INKTBanner chart's image
Candel Therapeutics
Price$4.30
Change+$0.01 (+0.23%)
Volume$540.87K
CapitalizationN/A
MiNK Therapeutics
Price$0.75
Change-$0.04 (-5.06%)
Volume$28.26K
CapitalizationN/A
CADL vs INKT Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CADL vs. INKT commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongBuy and INKT is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (CADL: $4.30 vs. INKT: $0.75)
Brand notoriety: CADL and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 197% vs. INKT: 84%
Market capitalization -- CADL: $137.96M vs. INKT: $29.65M
CADL [@Biotechnology] is valued at $137.96M. INKT’s [@Biotechnology] market capitalization is $29.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, CADL is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while INKT’s TA Score has 6 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 2 bearish.
  • INKT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INKT is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а -15.52% price change this week, while INKT (@Biotechnology) price change was +2.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

CADL is expected to report earnings on Nov 14, 2024.

INKT is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($138M) has a higher market cap than INKT($29.7M). CADL YTD gains are higher at: 192.517 vs. INKT (-29.907).
CADLINKTCADL / INKT
Capitalization138M29.7M465%
EBITDAN/AN/A-
Gain YTD192.517-29.907-644%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CADLINKT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
CADL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with INKT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+0.23%
INKT - CADL
46%
Loosely correlated
-5.59%
NDTP - CADL
31%
Poorly correlated
N/A
NKTR - CADL
29%
Poorly correlated
-8.59%
TCBP - CADL
28%
Poorly correlated
-29.57%
HRGN - CADL
27%
Poorly correlated
N/A
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with CADL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-5.59%
CADL - INKT
45%
Loosely correlated
+0.23%
NKTR - INKT
36%
Loosely correlated
-8.59%
VINC - INKT
35%
Loosely correlated
-7.50%
CRIS - INKT
28%
Poorly correlated
+1.27%
NUVL - INKT
26%
Poorly correlated
-0.18%
More